LITERATURE REVIEW
ARTICLE REVIEW
Catheter-Associated Thrombosis:Thromboprophylaxis or Not?Levine M, Kakkar AKJ Clin Oncol. 2005;23:4006-4008
001: 1O.2309/java.II-I-8
C atheter-related thrombosis haslong been acknowledged as apotential complication for any
patient receiving a central venous accessdevice (CVAD). This editorial, written byLevine and Kakkar. reviews four trialswhere either low-dose warfarin or low-dose,molecular-weight heparin was used asthrombosis prophylaxis in patients who hadcancer and CVADs.
The authors suggest that two of the earlier trials that have been reviewed mayhave overestimated the incidence ofcatheter-related thrombosis.'" The authorsalso suggest that improvements in catheterconstruction materials and insertion andmaintenance techniques have contributedto the lower incidence of catheter-relatedthrombosis in recent years. On the basis ofthe results from these studies, Levine andKakkar assert that it is difficult to supportthe use of anti thrombotic prophylaxis inpatients with CVADs who have cancer.However, the authors acknowledge thatadditional, large-seale studies are required.
ReferencesI. Mooreal M, Alastrue A, Rull M, et al.
Upper extremity deep venous thrombosis in cancer patients with venousaccess devices--prophylaxis with a lowmolecular weight heparin (Fragmin).Thromb Haemost. 1996;75:251-253.
2. Bern MM, Lokich JJ, Wallach S, et al.Very low doses ofwarfarin can preventthrombosis in central venous catheters.A raodornized prospective trial. AnnIntern Med. 1990;112:423-428.
The new Neo-Natal1.9 FR Silicone PICe.It's Magic!
Corporation
NeoMagic™Devices for Pediatric Access
For information Contact:800-227-8162
www.hdccorp.com
2006 Volll No I .JAVA 21
Recommended
